Skip to content

Randomised controlled trial comparing complication rates of magnetic ureteric stent and stent on extraction strings for kidney stones

Evaluation of complication rates with magnetic stents compared to stent on extraction string in patients after uncomplicated ureteroscopy – randomised controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12624000215527
Enrollment
12
Registered
2024-03-05
Start date
2025-03-05
Completion date
2026-10-30
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Comparing the complication rate between 2 different types of ureteric stent (Magnetic stent vs stent on extraction strings) which are used during the surgical treatment of kidney stones. We believe that magnetic stent may have less complication and side effects than the stent on extraction string.

Interventions

In the operating room, ureteroscopy is performed for treatment of kidney stone disease., the average time is ~60 minutes. After ureteroscopy a magnetic ureteric stent will be inserted by the operating surgeon which takes ~ 2 minutes before the procedure is completed. This magnetic stent will then be removed by Urology Nurse routinely at day 7 after the ureteroscopy. This is performed in the outpatient department by inserting a magnetic catheter. This procedure takes < 5 minutes. Electronic medi

In the operating room, ureteroscopy is performed for treatment of kidney stone disease., the average time is ~60 minutes. After ureteroscopy a magnetic ureteric stent will be inserted by the operating surgeon which takes ~ 2 minutes before the procedure is completed. This magnetic stent will then be removed by Urology Nurse routinely at day 7 after the ureteroscopy. This is performed in the outpatient department by inserting a magnetic catheter. This procedure takes < 5 minutes. Electronic medical records will be used to monitor adherence.

Sponsors

Royal North Shore Hospital, Reserve Road, St Leonards, New South Wales, 2056
Lead SponsorHospital

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Sex: Male and female • Age: 18 years and above • Planned definitive ureteroscopy for urolithiasis

Exclusion criteria

• Expected to require MRI investigations within the next week. • Patients that are pregnant • Intra-operative finding or complication that would change usual post-operative plan or follow up • Patients with untreated pre-operative urinary tract infection prior to procedure • Urothelial malignancy impacting ureteric stent choice • Patients with significant medical conditions that contra-indicate stent insertion will not be included in the study such as outlet obstruction and bladder fistula • Unable to provide informed consent or meet study requirements.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026